| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 9, 2020New Signatera™ Data to be Presented at the 2020 ESMO IO Congress from the Phase III IMvigor010 TrialVirtual Press Office and PR Newswire: General Trade show news
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that new data will be presented on its personalized and tumor-informed molecular residual disease...
-
Dec 9, 2020Virtual Press Office and PR Newswire: General Trade show news
Bolt Biotherapeutics, a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems, today announced the...
-
Dec 9, 2020Virtual Press Office and PR Newswire: General Trade show news
- First results from the independent SWOG Cancer Research Network-led Phase III study to be presented at the 2020 San Antonio Breast Cancer Symposium - RxPONDER results from over 5,000 women...
-
Dec 9, 2020Virtual Press Office and PR Newswire: General Trade show news
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will be presenting at the 13th annual LD Micro Main Event investor conference on Monday, December 14 at...
-
Dec 9, 2020Virtual Press Office and PR Newswire: General Trade show news
Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology and neuroscience, announced today the presentation of new preclinical data on...
